Submit manuscript...
eISSN: 2575-906X

Biodiversity International Journal

Correspondence:

Received: January 01, 1970 | Published: ,

Citation: DOI:

Download PDF

Abstract

Medicinal mushrooms have been used since olden days for the treatment of various diseases. Ganoderma lucidum or Reishi is a medicinal mushroom of significant importance which is gaining popularity due to the presence of numerous bio-active ingredients in it. Wild collection of this mushroom along with its cultivation is done worldwide to meet its ever-increasing demand in the market. Although, artificial or sawdust method of its cultivation on different woody substrates is commonly used but wood log cultivation method is also in practice. The steps for its cultivation include spawn preparation, substrate preparation, fruiting body management, harvesting and storage with their own set of requirements and precautions for each step. Several healthcare, personal care, food and beverage products made of its extract are being marketed and consumed worldwide. In this review, a general understanding about the cultivation of medicinal mushroom Ganoderma lucidum, current market scenario and its potential in Indian markets are discussed.

Keywords: medicinal mushroom, ganoderma lucidum, cultivation technique, spawn, marketing

Introduction

Medicines play an important role in treatment of various diseases. These medicines are consumed mostly in the form of drugs extracted from plants or other herbal sources. Among the herbal medicines, medicinal mushrooms have been used for curing several diseases as well as in maintaining good health from a long time. Ganoderma lucidum is one of the most popular and important medicinal mushroom which has been used for strengthening the body system since thousands of years. The name Ganoderma is derived from the Greek word- ganos "brightness, sheen", hence "shining" and derma "skin".1 It’s fruiting body is called “Lingzhi”, Chi–zhi” or “Rui–zhi” in China, “Reishi”, “Munnertake” or “Sachitake” in Japan and “Youngzhi” in Korea.2,3 This mushroom is often called as “Mushroom of Immortality”, “Herb of spiritual potency” and “Celestial Herb” due to its various medicinal properties.4,5,6

Ganoderma lucidum is known since around 2000 years and has played a very significant role as a medicine in Chinese and Japanese culture.7 Lingzhi, as a medicinal mushroom with various medicinal properties was also recorded in the first Chinese Pharmacopeia written in Ming Dynasty (A.D. 1590).8 This mushroom has often been portrayed in ancient Chinese art and literature. There also have been some assertions that the basic concept of ‘Lingzhi’ was originated in India as an expression of “Soma”, a vedic plant “Soma-Haoma”.9 The reports on Chinese edible and medicinal mushrooms accepted G. lucidum as the scientific binomial of “Lingzhi”.

Ganoderma lucidum is a fungus which belongs to the family Polyporaceae (or Ganodermaceae) of class Basidiomycetes10. It grows on dead wood and various parts of the fungus viz., mycelia, spores and its fruiting body are consumed and sold in various forms as powder, capsule, tea, coffee etc. Currently this mushroom is being used in treatment of various diseases and disorders worldwide. Cultivation of this mushroom is being done intensively in countries all around the world especially South-east Asian countries for manufacturing various health products which are being marketed and consumed worldwide. India is one of the largest market which, in recent time is flooded with herbal products including Ganoderma products. With increasing awareness towards Ganoderma based products along with easy accessibility of these products through online and multi level marketing, Ganoderma business is increasing continuously and creating tons of opportunities for the Ganoderma based businesses.                               

Morphology

Fruiting bodies of G. lucidum collected from India are kidney-shaped or irregular, mostly with thick margin along with long thick corky, hard stipe of dark brown in color (fruiting bodies also found without stipe, attached to the base of the tree with a dark thick pileus- G. applanatum). Basidiospores are double walled, ellipsoid with top cut flat/ovate with a rounded base and truncate to narrowly rounded apex/globoid shape. Size of Basidiospores varies between 6.24 µm -9.08µm ×9.11 µm -12 µm.11 Pileus of G. lucidum is kidney shaped, elongated, red to reddish brown with or without bright yellow and white margins when mature. Its tubes are up to 2 cm deep with white pores of 0.1 cm. and usually bruising brown in colour. The stipe is 3-12 cm. long with 1-2 cm. thickness, brown coloured spore prints and smooth, cylindrical dark red-black coloured crust.12 According to Bhosle et al.,13 basidiocarp of Ganoderma lucidum var. capense is 7–12×11–19×1.5 cm, woody to corky, sub sessile to laterally stipitate with 2–3 cm long, reniform with laccate, dark red-purple upper surface which is yellowish, brittle and soft towards margin. Its basidiospores were yellowish brown and of 8.3–10×6.6µm. dimensions. Basidiocarp of G. lucidum var. lucidum, as described by Bhosle et al.,13 was laterally stipitate or eccentric, 12–14 × 8–9 × 1.6 cm., laccate, brittle, stipe reddish black, 7–10 cm long. Its upper surface was radially sulcate, semidull with dark reddish brown colour and yellowish to brown thin margin, basidiospore 7–8.5 × 5–6 µm. The Chinese G. lucidum has cream to buff colored context.14

Distribution and ecology

Ganoderma species is distributed worldwide from tropical to subtropical regions due to its likeliness towards hot and humid climate. It is a facultative parasite which can also live as saprobe by feeding off and rotting stumps and roots of trees. It is a pathogenic, wood decaying fungus which causes the butt root, root and stem rot in perennial crops and economically important trees especially in tropical countries.15 The species of Ganoderma have a wide host range, with more than 44 species from 34 genera of plants being identified as potential hosts.16

Ecologically, Ganoderma species play an important role in breaking down the woody plants for nutrient mobilization. It is effective in production of bioenergy and used in bioremediation as it contains the mechanism of lignocellulose decomposing enzyme.15–18 Ganoderma species is responsible for the loss of forestry yields by causing the root and stem rots in various tree species like, Areca catechu,19 Camilliasinensis, Cocosnucifera,20 Elaeisguineensis21 and Heveabrasiliensis22 worldwide.

Chemical constituents and importance

Ganodermalucidum is an important medicinal mushroom due to presence of various bioactive chemical constituents which reflects different biological properties and are generally used as cure of various diseases, as health tonics, cosmetics etc. Various researches have proved the therapeutic properties of this mushroom. This mushroom contains about 90% water, rest 10% of dry matter is rich in protein (10-40%), fat (2-8%), carbohydrate (3-28%), fiber (3-32%) and ash (8-10%), Calcium, minerals, Phosphorus, Potassium, Copper, Iron, Zinc, Magnesium and selenium on fresh weight basis.23 More than 400 bioactive compounds like- polysaccharides, triterpenoid, nucleotides, steroids, fatty acids and other trace elements have been isolated and identified from its fruiting body, spores and mycelia. These ingredients have various pharmacological properties like anti-bacterial, anti-viral, anti-tumour, immunomodulation, sleep promotion, anti-ageing, anti-ulcer etc.24 Various studies have shown that the chloroform extracted from G.lucidum have the potential to delay the scavenging activities as well as the formation of free radicles.

Photographs of medicinal mushroom Ganodermalucidum(Figures 1–8).

Figure 1 Naturally growing Ganodermalucidum fruiting body on dead wood.

Figure 2 Ganodermalucidum fruiting body growing on dead and decaying wood.

Figure 3 Porous under surface of Ganodermalucidum fruiting body.

Figure 4 Pinhead stage of Ganodermalucidum.

Figure 5 Ganodermalucidum fruiting body with elongated stipe.

Figure 6 Young growing fruit body of Ganodermalucidum with yellow colour and white margin.

Figure 7 Fully developed Ganodermalucidum fruiting body.

Figure 8 Harvested and dried Ganodermalucidum fruiting bodies.

The immunomodulatory properties of G.lucidum have the potential to enhance the immune system and to reduce the toxicity in the cancer patients going through the chemotherapy or the radiation treatments. Zhuang et al.,25 reported the similar activity of G. lucidum dietary supplement in the reduction of leucopenia, neutropenia with the improvement in NK-cells and lymphocyte count. The studies and reports presented by Wang et al.,26 Lieu et al.,27 Cao& Lin28 and Chen et al.,29 also supported the immune modulatory activities of G. lucidum.

The anti-cancerous and anti-tumor activities of G. lucidum are associated with the immunomodulating effects of this mushroom as it has the potential to increase the recovery in patients recovering from cancer treatment. Polysaccharides and triterpenoids extracted from this mushroom have shown the cytotoxic activities against hepatoma cells.30 The compounds extracted from G. lucidum have also shown the decrease in leukemic cells.31 The study of Sliva et al.,32 indicated the high mortality of human breast and prostate cancer cells by the effect of G. lucidum spores or dried fruiting bodies and is potential in cancer treatment.

In a study conducted by el-Mekkawy et al.,33 on the various compounds extracted from G.lucidum fruiting bodies, anti-HIV activity of Ganoderiol F and ganodermanontriol and moderate activity of ganoderic acid alpha, ganoderic acid B, ganoderiol A& B, ganoderic acid C1, 3 beta-5 alpha-dihydroxy-6 beta-methoxyergosta-7,22-diene and ganoderic acid H were observed. Gao et al.,34 observed the activity of Lucidenic acid O and lucidenic lactone extracted from G. lucidum fruiting bodies against HIV.

The alcohol and aqueous extract of G. lucidum fruiting bodies have shown the reduced blood sugar level in diabetic mice.35,36 Hypoglycemic effect of polysaccharides isolated from G. lucidum was observed by Xiao et al.,37 and Zhang& Lin.38 The reduction in plasma glucose levels in steroid induced rats was concluded in the study conducted by Sarker36 which confirms the anti-hyperglycemic, insulin-sensitivity and hyperlipidaemic activity of G. lucidum.

Kurtipek et al.,39 also concluded in their research that the polysaccharides present in G. lucidum have anti-inflammatory property and it can be an option for treating and managing skin diseases with inflammation such as cutaneous sarcoidosis. 

The activity G. lucidum against various gram positive and gram negative bacteria is observed in several studies. G.lucidum also exhibits the properties like anti-fungal, anti-allergic, anti-angeogenic, anti-ulcerogenic, anti-mutagenic, anti-proliferative activities, cardiovascular and hepatoprotective activities.

Artificial cultivation

The collection Ganoderma lucidum fruiting bodies from wild was unable to meet the demand for the commercial production of its products. The collection of Ganoderma and maintaining its quality is quite difficult in wild. Only wealthy people had the privilege for the collection of Ganoderma from wild and its consumption in ancient times unlike now a day where most of Ganoderma is cultivated and is commonly consumed by general people. Although the artificial cultivation of Ganoderma started in 1937, it was successfully cultivated by the technicians of Institute of Microbiology, Chinese Academy of Sciences, Beijing in year 1969 by using the spore separation cultivation method.40 After that, Ganoderma cultivation became popular in Asian countries like China, Japan and Korea.41

Since 1969, the cultivation of Ganoderma was done by the inoculation of one meter long unsterilized natural logs and then burying them in a trench.9 Mainly, the broad-leaved hardwood logs are cut from living trees and can be used in Ganoderma cultivation.42 It takes around 6-24 months for its fruiting bodies to appear but the crop could be continued upto five years.42 Various other methods like basswood cultivation, sawdust cultivation and substitute cultivation have also been tried. Various different substrates such as- wood logs, grain, sawdust, tea wastes, cotton seed husk, farm crop residues, sunflower seed hull, cork residue, corn cobs, olive oil press cakes, wheat straw etc. are being used for the artificial cultivation of G. lucidum. By altering the growth conditions mainly temperature and CO2 volume, one can attain various growth forms including antlers-like structures.9 As compared to sawdust synthetic log cultivation method, lower yield and extended production time can be expected in natural log cultivation method.43

The cultivation technique of G. lucidum is divided majorly into two patterns based on the medium of cultivation. Solid state medium (SSM) cultivation method is used for the production of fruiting body, spore and mycelium biomass but the Liquid state medium (LSM) is used for the cultivation by mycelia biomass only.44 To obtain the desired products with excellent quality of mycelial biomass along with desired biochemical products in shorter time, the advance fermentation techniques are preferred choice.2 The cultivation pattern of G. lucidum can be divided into two parts-Solid State Fermentation (SSF) and Liquid State Fermentation (LSF) on the basis of the medium on which it is cultivated.45

In the liquid state/submerged fermentation process, the method of cultivation is done on liquid medium with Nitrogen and Carbon as the principle nutrient source. If our product of interests is Ganoderic acid and polysaccharides one can get it in 2-3 weeks through submerged fermentation as compared to substrate cultivation which takes 3-5 months.45 The production is mainly done in two stages- Preparation of spawn or mother culture and preparation of substrate material for the fruiting body cultivation. Mainly two methods of substrate cultivation- wood log cultivation and substitute cultivation are used in the commercial production of G. lucidum fruiting bodies.

Spawn preparation

The sterilized substrate after cooling is inoculated by the seed inoculum or spawn of mainly two types: liquid spawn and solid spawn. Potato-Dextrose Broth (PDB) or other formulations are used to prepare the pure culture liquid mycelial spawn. The type of solid spawn can be identified on the basis of substrate used like: grain spawn, sawdust-bran spawn, dowels, grooved woody plugged spawn etc.44 Spawn bags for each substrate or substrate mixtures are prepared by filling up prepared mixture or substrate like wheat, sorghum, maize, saw dust in polypropylene bags of required size (preferably 1 kg. or 5 kg.) and packed tightly using heat resistant Polyvinyl chloride (PVC) tube in the mouth of the bag. After plugging its neck with cotton, it is covered with sterile brown paper and tied with rubber band. These packets with PVC necks are then sterilized by autoclaving them at 120ºC and 1.5 Kg/cm2 pressure for one hour. After sterilization, these packets are transferred into clean aseptic chamber for cooling it for 24 hours.46,47,48,11 The polypropylene bags are then inoculated with young growing culture of G. lucidum under aseptic conditions by removing the cotton plug from the mouth of the bag and incubated for 8-10 days to get the bags ready for inoculation into the fruiting substrates.11

Substitute/sawdust cultivation

For the cultivation of G. lucidum, sawdust and mixed sawdust of various tree species i.e. Albizia sp., Alnusnepalensis, Bombaxceiba, Borasusflabellifer, Dalbergiasisoo, Eucalyptus sp., Mangiferaindica, Shorearobusta were also used as substrate.49,50 Other than wood, various other substrates are also used for the cultivation of G. lucidum. Riu et al.,51 identified cork residues as a substrate for its cultivation along with Peksen& Yakupoglu52 who identified tea waste as its substrate. González–Matute et al.,53 studied its growth on sunflower seed hulls. Corn cobs and olive oil press cakes were also used as a substrate for G. lucidum cultivation by Ueitele et al.,54 and Gregori & Pohleven55 respectively. Zhang& Wang56 also cultivated it on farm crop residue.

According to Mehta et al.,57 inoculation of spawn at the rate of 3% of dry weight of substrate results in shortest growth cycle and maximum yield. This sawdust is brought to 65% moisture by wetting after mixing it with 20% wheat bran. To obtain a pH of 5.5 Gypsum (CaSO4) and lime (CaCO3) is added. Just like the spawn preparation, polypropylene bags are then filled with this mixed substrate and after putting a plastic ring its mouth is plugged with cotton. Sterilization of these bags is done in autoclave at 22 psi pressure for two hours. Substrate is then cooled down and spawned with wheat grain/sawdust spawn @3% on dry weight basis as G. lucidum is slow growing as compared to other mushrooms. At around 28-35ºC spawn run/incubation is done in closed rooms with high CO2 and darkness.58

Wood log cultivation

Wood log cultivation can be obtained through three methods which are by sterilizing- short wood log, wood log and stump. Among these three, short wood log cultivation method has the upper hand due to high quality fruiting body, short growth cycle and large number of spores.59 The cultivation on wooden billets is taken place in low cost mist chambers containing a sand bed at its base. Billets are then vertically buried in the sand bed after the complete colonization. These billets are than covered with a thin layer of garden soilinside a bamboo chamber. To maintain the 60-70% humidity and 25-30ºC temperature, these sand beds are watered twice a day and will be continued throughout the growing period.11

Preparation of logs and inoculation

Growth and yield of Lingzhi fruiting body depends greatly upon the tree species.60 Due to presence of bactericidal components, Lingzhi cannot be grown on softwood species and few hardwood species like–Camphor and Eucalyptus species.44 The tree segments are generally cut about 12-15 cm. long and 13 cm. diameter for good mycelial growth with each section flat.61 All freshly cut logs of equal length are dried to obtain the suitable moisture level for mycelia growth which is 35-42%. The logs needed to dry for about 15 days before tying them. These logs are tied tight and flat in plastic bags and are sterilized under high pressure steam sterilizer (0.5 Mega Pascal pressure for 1.5-2 hours). To avoid any contamination, the inoculation process of spawn should be done in properly sanitized area.44 After inoculation, the incubated logs are put for mycelium run at 26±1ºC and 60-70% RH for 15 days. Proper ventilation, humidity and contamination free conditions should be provided for good mycelial growth. Any exposure to light will trigger the initiation of primordial on the logs, which are usually formed after about 60-70 days of spawning.44

Burying logs in soil and fruiting body management

After appearance of fruiting body primordial, these logs are embedded directly into the soil, leaving the newly formed primordia above ground level. Before embedding the logs, solarization of well drained sandy soil should be done for at least two days. These bags are transferred into fruiting room where 25±1ºC temperature and 80-90% RH is maintained to promote cap formation.44 In the initial stage of fruiting body, the soil moisture should be maintained at 20-25% and 16-18% in high humus soil and sandy soil respectively, which will further reduced up to 18% and 15% respectively to avoid any mould growth. The management of fruiting body is different in its various stages. During the pileus differentiation, it is very important to reduce CO2 concentration by providing proper ventilation. The best quality fruiting body with dark brown colour cortex is grown at 25ºC. Proper irrigation, aeration, light, protection, harvesting and drying conditions should be provided. Regular inspections and management especially regulation of ventilation, light and humidity is carried out. The fruiting body will mature in about 18 days in average temperature of 25ºC and can be harvested.44 After that, fruiting bodies are air dried at 60ºC for 2-3 days and the underside of pileus should be facing down. Prolonged and improper drying of fruiting body reduces its quality and makes it vulnerable to the mould attacks.42  

The harvest time or number of harvest is generally termed as ‘Flush’. To continue the cultivation for the second and third flush under optimum growth conditions can be carried out although the yield reduces subsequently in each flush. Second flush can be harvested after two week of spawn run. Trichoderma sp., Mycogonepernicioso and Neurospora sp. are the main fungi which are harmful and required proper protection for Ganoderma cultivation. It should be also protected from insect pests like moths, beetles, termites and small animals such as snails and slugs.44

Ganoderma products and its global market

The annual sale of G. lucidum based products was estimated to be more than 2.5 billion USD in Asian countries including China, Japan and South Korea.62 Ganoderma lucidum has given prime importance in Chinese Pharmacopeia for prevention and treatment of many diseases. It has also been included in American Herbal Pharmacopoeia and Therapeutic Compendium.63

To enhance the metabolic function and body immune system, G. lucidum products are being commercialized as food and drug supplement. These products are commonly sold in the form of coffee, powder, tea, dietary supplements, spore products, drinks, syrups, toothpastes, soaps and lotions etc.61,64,65 Ganoderma is a part of many cosmetic products like skin lightening products in USA, Europe and Asian countries mainly in China and Korea.66 Ganoderma extract is used in many facial and cosmetic products due to its tyrosinase enzyme inhibiting activity which ultimately inhibit the melanin formation in skin.67,68 It is also used in hair stimulators for men because it lowers the dihydrotestosterone or prostatic hyperplasia levels.69

There are nearly 200 medicines containing Ganoderma along with more than 1,000 Ganoderma health & food products are available which are certified by Chinese government.70 Ganoderma lucidum is also used as the daily life food material such as soup, tea, wine, yoghourt etc.71 After 1990s, Ganoderma based products are being popular in Europe, Malaysia, North America and Singapore with China, Japan and Korea being its main producers and suppliers.72 In 1995, the world market for Ganoderma based natural health care products was 1628 million US dollars61 and the total estimated Ganoderma production of Japan during 1995 was approximately 500 MT. The worldwide Ganoderma production during 1997 was 4300 MT.73 During 2002 and 2003, The China Edible Fungi Association recorded about 36700 MT and 49200 MT of Ganoderma production respectively in China.74 The total worldwide production of Ganoderma lucidum in 2004 was estimated about 5000 MT-6000 MT, more than half of which was produced by China alone.75,76 Three types of Ganoderma developmental products which are mainly based on Ganoderma fruiting bodies,76 mycelia77 and spore powder78 have been classified. Globally, More than 100 brands and 780 products of Ganoderma have been commercialized and sold.64,65 USA is the largest market for Ganoderma and related products.79 According to Li et al.,41 the largest producer and exporter of popular products of Ganoderma fruiting bodies, slices and spore powders among consumers is China with the capacity over 110,000 MT/year. China accounts for about 70% of global Ganoderma production but its exports is still low (less than 5% of total production) because of the lack of any internationally recognized GMP (Good Manufacturing Practice) certified manufacturing facilities in China.80 More than 100 research institutes specialized in Ganoderma studies and more than 200 factories situated in China are producing the Ganoderma based drugs and nutraceuticals along with the marketing of many patented products for the preparation of anti-tumor, liver function accelerant, lysozyme as antibiotic, shampoo and body shampoo, lowering of blood pressure & cholesterol levels, hypoglycemic activity, treatment of chronic bronchitis and immunomodulator.78 Various G. lucidum based products made from various parts of the mushroom are currently being sold in the market.81

In India, there is a rapid increase in Ganoderma-based nutri­ceuticals market which was estimated about $20 million USD in 2012.57 After China, India has the most population of internet users with 34.6% population using internet which has drastically increased the number of consumers using online marketing platform.82 Various Ganoderma based genuine and certified products are easily available on online shopping platforms like Amazon, Flipkart etc which is a game changer for the herbal based products.

Conclusion

Ganoderma lucidum is a well-known medicinal mushroom possessing numerous medicinal properties which makes it suitable ingredient for a number of preparations in various medicine systems. Its history dates back almost two thousand years and has long been used as remedy for several diseases in many cultures especially Chinese and Japanese culture. Ganodermalucidum is found all over the world and naturally it can be seen in the forest as a wood decaying pathogen with a wide host range of mainly broad leaved species. Various biological properties of this mushroom make it useful in cure of diseases and improvement of overall health. These biological properties are due to the presence of bioactive constituents like polysaccharides, triterpenoid, nucleotides, steroids, fatty acids etc. in it. Mainly this mushroom is comprised of protein, fat, carbohydrate, fiber, ash, minerals and other elements. Along with its pharmacological properties like anti-bacterial, anti-viral, anti-tumor, immunomodulation, anti-ageing, anti-ulcer and many more, it is also used in daily life edible and cosmetic products. China, with almost half of total Ganoderma production worldwide, is the largest producer and consumer of Ganoderma and its products. Along with China, countries like Japan and Korea are main producers of G. lucidum with USA being the largest market for Ganoderma and related products. As far as Indian market is concerned there is a growing demand for Ganoderma based products. Farmers and common people are not very aware of medicinal mushrooms from business point of view yet but efforts are being made to create awareness and interest among farmers towards G. lucidum cultivation as an additional source of income. Despite all the challenges, there is a great potential for farmers, growers and entrepreneurs for the production, value addition and marketing of G. lucidum based products.

Acknowledgments

The authors are thankful to National Mission on Himalayan Studies (NMHS), GB Pant National Institute of Himalayan Environment, Almora, Ministry of Environment, Forest and Climate change, Government of India for financial assistance to the project “Adoption of Medicinal and Edible Mushroom integrated with climate resilient interventions for up-scaling livelihoods in Garhwal Himalaya” (Project ID- NMHS/2018-19/SG61/61) vide sanction letter No. NMHS/2018-19/SG 7/212. The authors are grateful to the Prof. A.K. Karnataka, Vice Chancellor VCSG Uttarakhand University of Horticulture and Forestry, Bharsar, Uttarakhand, India and Prof. S.P. Singh, President, Center for Business Development and Entrepreneurial Development (CBED), Dehradun, Uttarakhand, India for support and encouragements. The authors are thankful for technical help and guidance provided by Dr. N.S.K. Harsh, former Scientist, Forest Research Institute, Dehadunand consultantto Ganoderma project and CBED, Dehradun, Uttarakhand, India. The help extended by authorities and supporting staff of VCSGUUHF, Bharsar and implementing partner CBED, Dehradun are highly acknowledged. The beneficiaries of project implementation sites Manjgaon, Tehri Garhwal and Sherpur, Dehradun of Uttarakhand are thankfully acknowledged.

Conflicts of interest

The author declares there are no conflicts of interest.

References

  1. Liddell GH, Scott RA Greek-English Lexicon (Abridged Edition). United Kingdom: Oxford University Press. 1980.
  2. Wagner R, Mitchell DA, Sassaki GL et al. Current techniques for the cultivation of Ganoderma lucidum for the production of biomass, ganoderic acid and polysaccharides. Food Technol Biotechnol. 2003;41:371–82.
  3. Paterson RRM. Ganoderma a therapeutic fungal bio factory. Phytochemistry. 2006;67:1985–2001.
  4. Wasser SP. Reishi or Ling Zhi (Ganoderma lucidum). In: Coates PM, Blackman MR, et al. Editors. Encyclopedia of dietary supplements. Marcel Dekker, New York. 2005;603–622.
  5. Lin ZB. Lingzhi: from mystery to science. Peking University Medical Press. Beijing. 2009;1–162.
  6. De Silva DD, Rapior S, Fons F, et al. Medicinal mushrooms in supportive cancer therapies: an approach to anti–cancer effects and putative mechanisms of action. Fungal Diversity. 2012;55:1–35.
  7. Sliva D. Ganoderma lucidum in cancer research. Leukemia Research. 2006;30:767–768.
  8. Wachtel Galor S, Yuen J, Buswell JA. Ganodermalucidum(Lingzhi or Reishi): A Medicinal Mushroom. In: Benzie IFF, Wachtel-Galor S, editors. Herbal Medicine: Biomolecular and Clinical Aspects. 2nd edn. Boca Raton (FL), CRC Press/Taylor & Francis. Chapter 9. 2011.
  9. Pegler DN. Useful fungi of the world: the Ling-zhi–the mushroom of immortality. Mycologist. 2002;16(3):100–101.
  10. Alexopoulos C. Introductory Mycology. John Wiley, New York. 1962.
  11. Singh S, Harsh NSK, Gupta PK. A novel method of economical cultivation of medicinally important mushroom, Ganoderma lucidum. Int J Pharma Sc Res. 2014;5:2033–2037.
  12. Vishwakarma MP, Bhatt RP, Gairola S. Some medicinal mushrooms of Garhwal Himalaya, Uttarakhand, India. Int J Med Arom Plants. 2011;1(1):33–40.
  13. Bhosle S, Ranadive K, Bapat G, et al. Taxonomy and Diversity of Ganoderma from the Western parts of Maharashtra (India). Mycosphere. 2010;1(3):249–262.
  14. Wang XC, Xi RJ, Li Y, et al. The species identity of the widely cultivated Ganoderma, ‘G. lucidum’ (Ling–zhi), in China. PLoS ONE. 2012;7(7):40857.
  15. Coetzee MP, Marincowitz S, Muthelo VG, et al. Ganoderma species, including new taxa associated with root rot of the iconic Jacaranda mimosifolia in Pretoria, South Africa. IMA Fungus. 2015;6(1):249–256.
  16. Venkatarayan SV. The biology of Ganoderma lucidumon areca and coconut palms. Phytopathology. 1936;26(2):153–175.
  17. Hepting GH. Diseases of forest and shade trees of the United States. US Department of Agriculture. Agricultural Handbook. 1971;386:1–658.
  18. Adaskaveg JE, Blanchette RA, Gilbertson RL. Decay of date palm wood by white–rot and brown–rot fungi. Canadian J Botany. 1991;69(3):615–629.
  19. Singh G. Ganoderma- The scourge of oil palms in the coastal areas. Planter. 1991;67(786):421–444.
  20. Kinge TR, Mih AM. Diversity and distribution of species of Ganoderma in South Western Cameroon. J Yeast Fungal Res. 2015;6(2):17–24.
  21. Glen M, Bougher NL, Francis AA, et al. Ganoderma and Amaurodermaspecies associated with root–rot disease of Acacia mangiumplantation trees in Indonesia and Malaysia. Australasian Plant Pathology. 2009;38:345–356.
  22. Monkai JM, Hyde KD, Xu JC, et al. Diversity and Ecology of soil fungal communities in rubber plantation. Fungal Biology Reviews. 2016;31:1–11
  23. Zhou X, Lin J, Yin Y, et al. Ganodermataceae: natural products and their related pharmacological functions. Am J Chin Med. 2007;35(04):559–574.
  24. Sanodiya BS, Thakur GS, Baghel RK, et al. Ganoderma lucidum: a potent pharmacological macrofungus. Curr Pharma Biotechnol. 2009;10(8):717–742.
  25. Zhuang SR, Chen SL, Tsai JH, et al. Effect of citronellol and the Chinese medical herb complex on cellular immunity of cancer patients receiving chemotherapy/radiotherapy. Phytotherapy Res. 2009;23(6):785–790.
  26. Wang SY, Hsu ML, Hsu HC, et al. The anti-tumor effect of from Ganoderma lucidum mediated by cytokines related from activated macrophags and T-Lymphocytes. Int J Cancer. 1997;70(6):699–705.
  27. Lieu CW, Lee SS, Wang SY. The effect of Ganoderma lucidum on induction of differentiation in leukemic U937 cells. Anticancer Res. 1992;12(4):1211–1215.
  28. Cao LZ, Lin ZB. Regulation on maturation and function of dendritic cells by Ganodermalucidum. Immunol Lett. 2002;83(3):163–169.
  29. Chen Y, Xie MY, Gong XF. Microwave-assisted extraction used for the isolation of total triterpenoid saponins from Ganodermaatrum. J Food Eng. 2007;81:162–170.
  30. Toth JO, Luu B, Beck JP, et al. Chemistry and biochemistry of oriental drugs. Part IX. Cytotoxic triterpenes from Ganodermalucidum (Polyporaceae): structures of ganoderic acids U-Z. J Chem Res Synop. 1983;12:299.
  31. Zhong L, Jiang DZ, Wang QR. Effects of Ganodermalucidum (Leyss ex Fr) Karst compound on the proliferation and differentiation of K562 leukemic cells. J Hunan Med Univ. 1999;24(6):521–524.
  32. Sliva D, Labarrere C, Slivova V, et al. Ganoderma lucidum suppresses motility of highly invasive breast and prostate cancer cells. BiochemBiophys Res Commun. 2002;298(4):603–612.
  33. El-Mekkawy S, Meselhy MR, Nakamura N, et al. Anti-HIV-1 and anti-HIV-1-protease substances from Ganoderma lucidum. Phytochemistry. 1998;49(6):1651–1657.
  34. Gao Y, Zhou SH, Huang M, et al. Antibacterial and antiviral value of the genus Ganoderma P. Karst. Species (Aphyllophoromycetideae): a review. Int J Med Mushroom. 2003;5(3):235–246.
  35. Seto SW, Lam TY, Tam HL, et al. Novel hypoglycemic effects of Ganodermalucidum water-extract in obese/diabetic (+db/+db) mice. Phytomedicine. 2009;16(5):426–436.
  36. Sarker MMR. Antihyperglycemic, insulin-sensitivity and anti-hyperlipidemic potential ofGanodermalucidum, a dietary mushroom, onalloxan-and glucocorticoid-induced diabetic Long-Evans rats. Funct. Foods Health Dis. 2015;5(12):450–466.
  37. Xiao C, Wu QP, Cai W, et al. Hypoglycemic effects of Ganoderma lucidumpolysaccharides in type 2 diabetic mice. Arch. Pharmacal Res. 2012;35(10):1793–1801.
  38. Zhang HN, Lin ZB. Hypoglycemic effect of Ganoderma lucidumpolysaccharides. Acta Pharmacol Sin. 2004;25(2):191–195.
  39. Kurtipek SG, Ataseven A, Kurtipek E, et al. Resolution of Cutaneous Sarcoidosis Following Topical Application of Ganodermalucidum (Reishi Mushroom). Dermatology and therapy. 2016;6(1):105–109.
  40. Yu, YN, Shen MZ. The history of Lingzhi (Ganoderma spp.) cultivation. Mycosystema. 2003;22:3–9.
  41. Li S, Dong C, Wen HA, et al. Development of Ling-zhi industry in China–emanated from the artificial cultivation in the Institute of Microbiology, Chinese Academy of Sciences (IMCAS). Mycology. 2016;7(2):74–80.
  42. Chen AW. Natural log cultivation of the medicinal mushroom, Ganodermalucidum(Reishi). Mushroom Growers’s Newsletter. 2002;3(9):2–6.
  43. Chen KL, Chao DM. Ling Zhi. (Ganodermaspecies), In: Hsu KT, editor. Chinese medicinal mycology. United Press of Beijing Medical University and Chinese United Medical University, Beijing, China. 1997;496–517.
  44. Zhou X. Cultivation of Ganoderma lucidum: Technology and Applications. Ed Med Mushrooms. 2017:385–413.
  45. Tang YJ, Zhong JJ. Exopolysaccharide biosynthesis and related enzyme activities of the medicinal fungus, Ganoderma lucidum, grown on lactose in a bioreactor. Biotechnol Lett. 2002;24:1023–1026.
  46. Uddin MN, Yesmin SM, Khan A, et al. Production of oyster mushrooms in different seasonal conditions of Bangladesh. J Sci Res. 2011;3(1):161–167.
  47. Azizi M, Tavana M, Farsi M, et al. Yield performance of lingzhi or reishi medicinal mushroom, Ganodermalucidum (W.Curt.:Fr.) P. Karst. (higher basidiomycetes), using different waste materials as substrates. IntJ Med Mushroom. 2012;14(5):521–527.
  48. Kakon AJ, Choudhury MBK, Saha S. Mushroom is an ideal food supplement. J Dhaka National Medical College and Hospital. 2012;18(1):58–62.
  49. Hossain K, Sarker NC, Kakon AJ, et al. Cultivation of Reishi Mushroom (Ganodermalucidum) on Sawdust of Different Tree Species. Bangla J Mushroom. 2009;3:1–5.
  50. Gurung OK, Budathoki U, Parajuli G. Effect of Different Substrates on the Production of Ganodermalucidum(Curt.:Fr.) Karst. Our Nature. 2012;10(1):191–198.
  51. Riu H, Roig G, Sancho J. Production of carpophores of Lentinusedodesand Ganoderma lucidumgrown on cork residues. Microbiologia SEM. 1997;13(2):185–192.
  52. Peksen A, Yakupoglu G. Tea waste as a supplement for the cultivation of Ganoderma lucidum. World J Microbiol Biotechnol. 2009;25:611–618.
  53. González Matute R, Figlas D, Devalis R, et al. Sunflower seed hulls as a main nutrient source for cultivating Ganoderma lucidum. Micología Aplicada International. 2002;14:19–24.
  54. Ueitele ISE, Kadhila MNP, Matundu N. Evaluating the production of Ganoderma mushroom on corn cobs. African J Biotechnol. 2014;13(22):2215–2219.
  55. Gregori A, Pohleven A. Cultivation of three medicinal mushroom species on olive oil press cakes containing substrates. Acta Agriculturae Solvonica. 2014;103(1):49–54.
  56. Zhang LH, Wang SX. Study on the binding and packing cultivation technology of the G. lucidum’sartificial alternative compost. Agric Technol Service. 2010;27:516–517.
  57. Mehta S, Jandaik S, Gupta D. Effect of Cost-Effective Substrates on Growth Cycle and Yield of Lingzhi or Reishi Medicinal Mushroom, Ganodermalucidum (Higher Basidiomycetes) from Northwestern Himalaya (India). Int J Med Mushrooms. 2014;16(6):585–591.
  58. National Research Centre for Mushroom.n.d.Cultivation of Reishi Mushroom (Ganodermalucidum) [Brochure].Solan, India; Dr. R.P. Tewari.
  59. Lin X, Li K, Chen T, et al. A study on the cultivation properties of eleven strains of Ganoderma lucidum and their esterase isozymes. Acta Agriculurae Universitatis Jiangxiensis. 2001;23(1):80–84.
  60. Hou RH, Liau ST. Research development of the artificial cultivation of Ganoderma lucidum in China. Guang Dong Agric Sc. 2009;11:29–32.
  61. Chang ST, Buswell JA. Ganoderma lucidum(Curt. Fr.) P. Karst. (Aphyllophoromyce-tideae) – A mushrooming medicinal mushroom. Int J Med Mushrooms.1999;1(2):139–146.
  62. Li J, Zhang J, Chen H, et al. Complete Mitochondrial Genome of the Medicinal Mushroom Ganoderma lucidum. Plos one. 2013;8(8):72038.
  63. Hapuarachchi KK, Elkhateeb WA, Karunarathna SC, et al. Current status of global Ganoderma cultivation, products, industry and market. Mycosphere. 2018;9(5):1025–1052.
  64. Lai T, Gao Y, Zhou SF. Global marketing of medicinal Ling Zhi mushroom Ganodermalucidum(W.Curt:Fr.) Lloyd (Aphyllophoromycetideae) products and safety concerns. Int J Med Mushrooms. 2004;6(2):189–194.
  65. Singh SK, Doshi A, Pancholy A, et al. Biodiversity in wood–decay macro–fungi associated with declining arid zone trees of India as revealed by nuclear rDNA analysis. Euro J Pl Path. 2013;136:373–382.
  66. Jiang L. Ganodermalucidum(Reishi Mushroom): Potential Application as Health Supplement and Cosmeceutical Ingredient. Global Journal for Research Analysis. 2015;4(9):124–125.
  67. Chien C, Tsai M, Chen C, et al. Effects on Tyrosinase Activity by the Extracts of Ganoderma lucidum and Related Mushrooms. Mycopathologia. 2008;166(2):117–120
  68. Hyde KD, Bahkali AH, Moslem MA. Fungi – An unusual source for cosmetics. Fungal Diversity. 2010;43:1–9.
  69. Meehan K. Composition to Promote Hair Growth in Humans. U.S. Patent US9144542. 2015.
  70. Chen RY, Kang J, Du GH. Construction of the quality control system of Ganoderma Products. Ed Med Mushrooms. 2016;24(6):339–344.
  71. Dong C, Han Q. Ganoderma lucidum (Lingzhi, Ganoderma): Fungi, algae, and other materials. In: Liu Y, Wang Z, Zhang J. editors. Dietary Chinese Herbs Chemistry: Pharmacology and Clinical Evidence Springer, London. 2015;759–765.
  72. Chang ST, MillsPG. Mushrooms: Cultivation, Nutritional Value, Medicinal Effect, and environment impact. CRC Press. 2004;357–372.
  73. Zhou SF, Gao YH. The immunomodulating effects of Ganoderma lucidum(Curt. Fr.) P. Karst. (Lingzhi, Reishi mushroom (Aphyllophoromycetideae). Int J Med Mushrooms. 2002;4(1):1–11.
  74. Banuelos GS, Lin ZQ. Use and development of Bio fortified Agricultural products. Boca Ratan, Florida, CRC Press. 2009;272–292.
  75. Rai RD. Successful cultivation of the medicinal mushroom Reishi, Ganodermalucidumin India. Mushroom Res. 2003;12:87–91.
  76. Wasser SP. Current findings, future trends, and unsolved problems in studies of medicinal mushrooms. Applied Microbiol Biotechnol. 2011;89(5):1323–1332.
  77. He H. Research advances and prospect on submerged fermentation technology of Ganoderma lucidum. Primary J Chin Mat Med. 2000;14:48–49.
  78. Xie YZ, Zhang Z, Li SZ, et al. Recent advances in the development and processing works of the Ling-zhi fungus. J Microbiol. 2002;22:43–45.
  79. Perumal K. Indigenous technology on organic cultivation of Reishi. AMM Murugappa Chettiar Research Centre. 2009;1–12.
  80. Pang A. Traditional Medicine in China, World Market Research Centre. 2002.
  81. Chang ST, Buswell JA. Safety, quality control and regulational aspects relating to mushroom nutraceuticals. Proceedings of the 6th International Conference Mushroom Biology and Mushroom Products. 2008;188–195.
  82. Suginraj M. Growth of online marketing in India: A study. International Journal of Research in Management & Business Studies. 2017;4(3):9–14.
Creative Commons Attribution License

© . This is an open access article distributed under the terms of the, which permits unrestricted use, distribution, and build upon your work non-commercially.